# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $226 to ...
B of A Securities analyst Craig Siegenthaler maintains CME Gr (NASDAQ:CME) with a Neutral and raises the price target from $...
JP Morgan analyst Kenneth Worthington maintains CME Gr (NASDAQ:CME) with a Neutral and raises the price target from $198 to ...
Keefe, Bruyette & Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:CME) with a Market Perform and raises the price targ...
Rosenblatt analyst Andrew Bond reiterates CME Gr (NASDAQ:CME) with a Sell and raises the price target from $185 to $187.
Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 3...
CME Gr (NASDAQ:CME) reported quarterly earnings of $2.50 per share which beat the analyst consensus estimate of $2.45 by 2.04 p...